ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135758 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135758; 2) Community: the network communities that were significantly associated with the response to NSC 135758; 3) Molecule: the relationships between components within communities and NSC 135758; 4) MDR: the compounds that were significantly associated with the NSC 135758.

NSC Compound Enrichment Correlation
NSC 718728 5-[2-(2,5-Dimethoxyphenyl)ethynyl]-2-methoxyphenyl-N- [2-(4-fluorophenyl)ethyl]carboxamide 0.0386895225700413 0.025458329
NSC 732317 6,7-dichloro-2-methyl-3-(phenylthio)quinoxaline 1,4-dioxide 0.0386895225700413 0.0028660244
NSC 740385 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide 0.0386895225700413 0.15330169
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0386895225700413 0.11923239
NSC 134727 MITOMYCIN C 0.0401206532535666 0.59061137
NSC 674092 Quinoline-4-carboxamide, N,N'-[(1,4-piperazinediyl) bis(3,1-propanediyl)]bis(2-phenyl-, dihydrochloride 0.040120653253567 -0.013424276
NSC 716261 Null 0.040120653253567 -0.11941202
NSC 163949 3,6-Diamino-10-methylacridinium chloride hydrochloride 0.0401206532535671 0.029885709
NSC 266046 Oxaliplatin 0.0401206532535671 0.35537623
NSC 27445 Null 0.0401206532535671 0.25722871
Total:49  Current:38    [First] [Prev] [Next] [Last]